L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model

Neurosurgery

Volumn 48, Issue 2, 2001, Pages 392-400

  Sipos, Eric P ^a   Witham, Timothy F ^a   Ratan, Rajiv ^a   Burger, Peter C ^a   Baraban, Jay ^a   Li, Khan W ^a   Piantadosi, Steven ^a,b   Brem, Henry ^a,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 Hydroxyperoxycyclophosphamide; Biodegradable polymer; Buthionine sulfoximine; Drug delivery; Glutathione

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; BUTHIONINE SULFOXIMINE; ETHYLENE VINYL ACETATE COPOLYMER; GLUTATHIONE; POLYMER;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; GLIOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 0035104948     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200102000-00032     Document Type: Article

References (69)

1. Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells
2. Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione
3. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine induced DNA-DNA cross-linking and cytotoxicity in human glioma cells
4. Prognostic significance of glutathione S-transferase π expression and subcellular localization in human gliomas
5. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines
6. Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells
7. Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant cells
8. Hepsulfam sensitivity in human breast cancer cell lines: The role of glutathione and glutathione S-transferase in resistance
9. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
10. Brain tumors: Part 1
11. Brain tumors: Part 2
12. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
13. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
14. Placebo-controlled trial of the safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: The Polymer-brain Tumor Treatment Group
15. Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts
16. Interstitial chemotherapy of experimental brain tumors: Comparison of intratumoral injection versus polymeric controlled release
17. Controlled release of 4-hydroperoxycyclophosphamide from the fatty acid dimer-sebacic acid copolymer
18. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines
19. Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine
20. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and -resistant rat ovarian tumors and its relation to DNA interstrand cross links
21. Role of glutathione in cellular resistance to alkylating agents
22. Regression models and life tables
23. Absorbable biopolymers derived from dimer fatty acids
24. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells
25. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard
26. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas
27. Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity
28. Cyclophosphamide resistance in medulloblastoma
29. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma
30. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion
31. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine
32. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)
33. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
34. Assumptions in the radiotherapy of glioblastoma
35. Determinants of tumor blood flow: A review
36. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies
37. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas
38. Chemotherapy for malignant gliomas
39. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine
40. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU)
41. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines
42. Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathionetargeted assay
43. Cardiac cell toxicity induced by 4-hydroperoxycyclophosphamide is modulated by glutathione
44. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine
45. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro
46. Buthionine sulfoximine treatment impairs rat diaphragm function
47. Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors
48. MDR hamster cells exhibiting multiple altered gene expression: Effects of dexniguldipine-HCl (B859-35), cyclosporin A and buthionine sulfoximine
49. Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine
50. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow
51. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione
52. Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K- 562 cells
53. Thiol manipulation as a means of overcoming drug resistance in a novel cyclophosphamide-induced resistant cell line
54. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity
55. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine
56. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation
57. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts
58. Experimental therapeutics and kinetics: Selection and overgrowth of specifically and permanently drug-resistant tumor cells
59. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells
60. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard
61. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis
62. Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity
63. Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content
64. Drug delivery to the central nervous system: A review
65. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain
66. Chemosensitization by buthionine sulfoximine in vivo
67. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse
68. Glutathione conjugation with phosphoramide mustard and cyclophosphamide: A mechanistic study using tandem mass spectrometry